Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alumis (ALMS) EBIT Margin (2025 - 2026)

Updated

Alumis' EBIT Margin came in at -8956.38% for Q2 2026, down 3684.85 percentage points from -5271.53% a year earlier.

Analysis

Alumis (ALMS) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alumis reported EBIT Margin of -6021.04%; for FY2025, it came in at -1886.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Alumis 870.27 Mn -804.57 Mn - -8,956.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,956.38%
Dec 31, 2025 -4,999.74%
Sep 30, 2025 -5,580.45%
Jun 30, 2025 -5,271.53%
Mar 31, 2025 -583.49%
API Access

Alumis EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY